FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2090823852> ?p ?o ?g. }

• W2090823852 endingPage "1977" @default.
• W2090823852 startingPage "1971" @default.
• W2090823852 abstract "Abstract Allogeneic bone marrow transplantation (BMT) offers the only curative therapy for chronic myelogenous leukemia. We compared prospectively collected results of 2464 unrelated donor (URD) transplantations with 450 HLA-identical, matched sibling donor (MSD) transplantations performed at collaborating National Marrow Donor Program institutions. A total of 63% of URDs were matched at HLA-A, -B, and at -DRB1 alleles; all MSDs were genotypically identical at major histocompatibility loci. URD recipients were younger (median 36 vs 39, P = .001) than MSDs and underwent BMT later after diagnosis (median 17 [0-325 months] vs 7 [1-118 months],P = .001) and less often in chronic phase (CP) (67% vs 82%, P = .001). Multivariate analysis demonstrated a significantly increased risk of graft failure and acute graft versus host disease after URD BMT. The risk of hematologic relapse was low after either matched URD or MSD transplantations. We observed significantly though modestly poorer survival and disease-free survival (DFS) after URD transplantations. However, for those undergoing transplantation during CP within 1 year from diagnosis, 5-year DFS was similar or only slightly inferior after matched URD versus MSD transplantation (age &lt; 30: URD 61% ± 8% vs MSD 68% ± 15%,P = .18; 30-40: URD 57% ± 9% vs MSD 67% ± 10%,P = .05; &gt; 40: URD 46% ± 9% vs MSD 57% ± 9%,P = .02). Delay from diagnosis to BMT in CP patients led to substantially poorer 5-year DFS after matched URD than MSD BMT (CP 1-2 years: URD 39% ± 6% vs MSD 63% ± 12%; beyond 2 years: URD 33% ± 7% vs MSD 50% ± 20%). Outcome of matched URD BMT for early CP chronic myelogenous leukemia yields survival and DFS approaching that of MSD transplantation. However, delay may compromise URD outcomes to a greater extent. Improvements in URD and MSD transplantation are still needed, and results of newer, nontransplantation therapies should be evaluated against the established curative potential of URD and MSD marrow transplantation." @default.
• W2090823852 created "2016-06-24" @default.
• W2090823852 creator A5023644095 @default.
• W2090823852 creator A5054037976 @default.
• W2090823852 creator A5060725545 @default.
• W2090823852 creator A5060783496 @default.
• W2090823852 creator A5070132319 @default.
• W2090823852 creator A5070736485 @default.
• W2090823852 creator A5071051461 @default.
• W2090823852 creator A5078053673 @default.
• W2090823852 creator A5091818686 @default.
• W2090823852 date "2002-03-15" @default.
• W2090823852 modified "2023-10-17" @default.
• W2090823852 title "Allogeneic bone marrow transplantation for chronic myelogenous leukemia: comparative analysis of unrelated versus matched sibling donor transplantation" @default.
• W2090823852 cites W107716097 @default.
• W2090823852 cites W1504399806 @default.
• W2090823852 cites W1973617793 @default.
• W2090823852 cites W1985926641 @default.
• W2090823852 cites W201756653 @default.
• W2090823852 cites W2025383600 @default.
• W2090823852 cites W2038990138 @default.
• W2090823852 cites W2050642909 @default.
• W2090823852 cites W2054448483 @default.
• W2090823852 cites W2106166590 @default.
• W2090823852 cites W2120756704 @default.
• W2090823852 cites W2122455557 @default.
• W2090823852 cites W2139274053 @default.
• W2090823852 cites W2140134889 @default.
• W2090823852 cites W2154101238 @default.
• W2090823852 cites W2288682663 @default.
• W2090823852 cites W2312804644 @default.
• W2090823852 cites W2325889210 @default.
• W2090823852 cites W2329648702 @default.
• W2090823852 cites W2337277825 @default.
• W2090823852 cites W2341215846 @default.
• W2090823852 cites W2358616132 @default.
• W2090823852 cites W2463564403 @default.
• W2090823852 cites W2508058084 @default.
• W2090823852 cites W315603462 @default.
• W2090823852 cites W4245888769 @default.
• W2090823852 cites W4293241248 @default.
• W2090823852 cites W44995847 @default.
• W2090823852 cites W58931608 @default.
• W2090823852 cites W60081501 @default.
• W2090823852 doi "https://doi.org/10.1182/blood.v99.6.1971" @default.
• W2090823852 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11877268" @default.
• W2090823852 hasPublicationYear "2002" @default.
• W2090823852 type Work @default.
• W2090823852 sameAs 2090823852 @default.
• W2090823852 citedByCount "182" @default.
• W2090823852 countsByYear W20908238522012 @default.
• W2090823852 countsByYear W20908238522013 @default.
• W2090823852 countsByYear W20908238522014 @default.
• W2090823852 countsByYear W20908238522015 @default.
• W2090823852 countsByYear W20908238522016 @default.
• W2090823852 countsByYear W20908238522017 @default.
• W2090823852 countsByYear W20908238522018 @default.
• W2090823852 countsByYear W20908238522019 @default.
• W2090823852 countsByYear W20908238522020 @default.
• W2090823852 countsByYear W20908238522021 @default.
• W2090823852 countsByYear W20908238522022 @default.
• W2090823852 countsByYear W20908238522023 @default.
• W2090823852 crossrefType "journal-article" @default.
• W2090823852 hasAuthorship W2090823852A5023644095 @default.
• W2090823852 hasAuthorship W2090823852A5054037976 @default.
• W2090823852 hasAuthorship W2090823852A5060725545 @default.
• W2090823852 hasAuthorship W2090823852A5060783496 @default.
• W2090823852 hasAuthorship W2090823852A5070132319 @default.
• W2090823852 hasAuthorship W2090823852A5070736485 @default.
• W2090823852 hasAuthorship W2090823852A5071051461 @default.
• W2090823852 hasAuthorship W2090823852A5078053673 @default.
• W2090823852 hasAuthorship W2090823852A5091818686 @default.
• W2090823852 hasBestOaLocation W20908238521 @default.
• W2090823852 hasConcept C126322002 @default.
• W2090823852 hasConcept C138496976 @default.
• W2090823852 hasConcept C141071460 @default.
• W2090823852 hasConcept C15744967 @default.
• W2090823852 hasConcept C2776194465 @default.
• W2090823852 hasConcept C2776694085 @default.
• W2090823852 hasConcept C2776755627 @default.
• W2090823852 hasConcept C2776960273 @default.
• W2090823852 hasConcept C2778461978 @default.
• W2090823852 hasConcept C2778880498 @default.
• W2090823852 hasConcept C2780007613 @default.
• W2090823852 hasConcept C2911091166 @default.
• W2090823852 hasConcept C71924100 @default.
• W2090823852 hasConcept C90924648 @default.
• W2090823852 hasConceptScore W2090823852C126322002 @default.
• W2090823852 hasConceptScore W2090823852C138496976 @default.
• W2090823852 hasConceptScore W2090823852C141071460 @default.
• W2090823852 hasConceptScore W2090823852C15744967 @default.
• W2090823852 hasConceptScore W2090823852C2776194465 @default.
• W2090823852 hasConceptScore W2090823852C2776694085 @default.
• W2090823852 hasConceptScore W2090823852C2776755627 @default.
• W2090823852 hasConceptScore W2090823852C2776960273 @default.
• W2090823852 hasConceptScore W2090823852C2778461978 @default.
• W2090823852 hasConceptScore W2090823852C2778880498 @default.
• W2090823852 hasConceptScore W2090823852C2780007613 @default.

• next